New Guidelines for Ebola and Marburg Treatment

By VirentaNews Staff — June 20, 2026

The World Health Organization (WHO) has released its first comprehensive guidelines for the clinical management of filovirus disease, which includes all types of Ebola and Marburg viruses, as the Democratic Republic of the Congo battles an Ebola disease outbreak caused by the Bundibugyo virus. The new guidelines, which outline 16 evidence-based recommendations, emphasize the importance of early supportive care to improve patient survival and health outcomes. This development comes at a critical time, as the global health community continues to grapple with the challenges of filovirus disease outbreaks, and the guidelines are expected to play a key role in informing treatment strategies and improving patient outcomes.

Background and Context

Filovirus diseases, including Ebola and Marburg, are highly infectious and often deadly, with mortality rates ranging from 25% to 90%. The WHO’s new guidelines are a significant step forward in the global response to these diseases, as they provide a comprehensive framework for healthcare workers and policymakers to follow. The guidelines are based on a thorough review of the latest scientific evidence and expert consensus, and they cover all aspects of clinical management, from diagnosis and treatment to infection prevention and control. By providing a standardized approach to the management of filovirus disease, the guidelines aim to reduce mortality rates and improve health outcomes for patients affected by these diseases.

Key Details and Recommendations

The WHO’s guidelines for the clinical management of filovirus disease include 16 evidence-based recommendations, which cover key aspects of patient care, such as fluid management, oxygen therapy, and the use of personal protective equipment (PPE). The guidelines also emphasize the importance of early supportive care, including the provision of fluids, electrolytes, and oxygen, as well as the management of symptoms such as fever, vomiting, and diarrhea. Additionally, the guidelines highlight the need for healthcare workers to follow strict infection prevention and control protocols, including the use of PPE and the implementation of robust contact tracing and surveillance systems. By following these recommendations, healthcare workers can reduce the risk of transmission and improve patient outcomes.

Analysis and Implications

The WHO’s new guidelines have significant implications for the global response to filovirus disease outbreaks, as they provide a standardized approach to the management of these diseases. The guidelines are expected to play a key role in reducing mortality rates and improving health outcomes for patients affected by filovirus diseases, and they will inform treatment strategies and policies at the national and international levels. Furthermore, the guidelines highlight the need for continued investment in research and development, as well as the importance of strengthening health systems and capacities in affected countries. As the global health community continues to grapple with the challenges of filovirus disease outbreaks, the WHO’s guidelines will provide a critical framework for informing response efforts and improving patient outcomes.

Global Impact and Response

The WHO’s guidelines for the clinical management of filovirus disease will have a significant impact on the global response to these diseases, as they provide a comprehensive framework for healthcare workers and policymakers to follow. The guidelines will inform treatment strategies and policies at the national and international levels, and they will play a key role in reducing mortality rates and improving health outcomes for patients affected by filovirus diseases. Additionally, the guidelines will highlight the need for continued investment in research and development, as well as the importance of strengthening health systems and capacities in affected countries. As the World Health Organization continues to work with countries and partners to respond to filovirus disease outbreaks, the new guidelines will provide a critical framework for informing response efforts and improving patient outcomes.

Expert Perspectives

Experts in the field of infectious diseases have welcomed the WHO’s new guidelines, highlighting their potential to improve patient outcomes and reduce mortality rates. According to Dr. Michael Ryan, Executive Director of the WHO’s Health Emergencies Programme, “these guidelines represent a significant step forward in the global response to filovirus disease outbreaks, and they will play a critical role in informing treatment strategies and policies at the national and international levels.” Other experts have emphasized the need for continued investment in research and development, as well as the importance of strengthening health systems and capacities in affected countries. As the global health community continues to grapple with the challenges of filovirus disease outbreaks, the WHO’s guidelines will provide a critical framework for informing response efforts and improving patient outcomes.

Looking ahead, the key question is how the WHO’s new guidelines will be implemented and scaled up in affected countries. The WHO will need to work closely with countries and partners to ensure that the guidelines are widely adopted and that healthcare workers have the necessary training and resources to follow them. Additionally, there will be a need for continued investment in research and development, as well as the importance of strengthening health systems and capacities in affected countries. As the global health community continues to respond to filovirus disease outbreaks, the WHO’s guidelines will provide a critical framework for informing response efforts and improving patient outcomes, and it will be important to monitor progress and identify areas for further improvement.

Source: WHO